Investors have a compelling, low-risk, specialty pharmaceutical company under their noses they may not know about. Capital Ideas Media president and publisher Mark Bunting sits down with Ken d’Entremont, CEO of Medexus Pharmaceuticals (TSXV:MDP), to find out about the company’s model of licensing existing drugs, its fast-growing revenue and operating profit, and how close the firm is to making a transformational deal using its $27 million in cash.
Episode 050 - John O'Connell, Chairman & CEO, Davis Rea Investment Counsel, Part Two.
Episode 049 - John O'Connell, Chairman & CEO, Davis Rea Investment Counsel, Part One.
Episode 046 - Dave Merheje, Business of Comedy Special
Episode 045 - Sean Cullen, Business of Comedy Special
Episode 044 - George Robinson, CEO, RavenQuest BioMed
Episode 043 - Kiran Sidhu, Founder, CEO, Halo Labs
Episode 042 - Aras Azadian, Co-Founder, CEO, Chairman, Avicanna
Episode 041 - SwapCast: Mark Bunting on the #HashtagFinance Podcast
Episode 040 - Aaron Dunn, Senior Analyst, KeyStone Financial
Episode 039 - Bruce Campbell, Founder & Portfolio Manager, StoneCastle Investment Management
Episode 038 - Mark Goliger, CEO, National Access Cannabis
Episode 037 - Tyler Robson, CEO, Valens GroWorks
Episode 036 - Paul Pedersen, Co-Founder & CEO, Nextleaf Solutions
Episode 035 - Bob Groesbeck, Co-CEO, Planet 13
Episode 034 - Marc Seelenfreund, Founder, CEO, Siyata Mobile
Episode 033 - Simon Hitzig, CEO, Accord Financial
Episode 032 - Dr. Jack Regan, Founder, CEO, Lexagene Holdings
Episode 031 - Paul Beattie, Co-Founder, BT Global Growth
Episode 030 - Dr. Zaki Rakib, Founder, CEO, Canna-V-Cell Sciences
The Dave Ramsey Show
The Clark Howard Podcast
The Grant Williams Podcast
Real Vision: Finance, Business & The Global Economy